Professor Shanta Dhar
Ph.D. is Assistant Professor of Chemistry at the University of Georgia.
Shanta earned her Ph.D. from the Indian Institute of Science, India. She was a postdoc at Johns Hopkins University where she developed sensors for detection of DNA lesions. In 2007, she joined MIT as an Anna Fuller fellow and worked on platinum-based cancer therapy.
Currently, she is an assistant professor in the chemistry department at the University of Georgia and an adjunct assistant professor in the Department of Physiology and Pharmacology. Her research program is in the field of nanomedicine. She was recently awarded with the Ralph E. Powe Junior Faculty Enhancement Award and the Department of Defense Idea award.
Shanta coauthored Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA—PEG nanoparticles, Targeted Single Wall Carbon Nanotube Mediated Pt(IV) Prodrug Delivery Using Folate as a Homing Device, Polyvalent Oligonucleotide Gold Nanoparticle Conjugates as Delivery Vehicles for Platinum(IV) Warheads, Effect of Steric Encumbrance of Tris(3-phenylpyrazolyl)borate on the Structure and Properties of Ternary Copper(II) Complexes Having N,N-Donor Heterocyclic Bases, Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo, and Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy. Read the full list of her publications!
Shanta earned her BSc (Honors) in Chemistry at the University of North Bengal, Darjeeling, India in 1996. She earned her MSc (Honors) in Chemistry at the University of North Bengal in 1998. She earned her Ph.D. in Bio-inorganic Chemistry at the Indian Institute of Science, Bangalore, India in 2005.
Read UGA researchers boost efficacy of drugs by using nanoparticles to target “powerhouse of cells”. Read her LinkedIn profile.